nach oben

Journal of Cancer Research and Clinical Oncology

Erschienen in:

08.06.2017 | Letter to the Editor

Commentary on: Men and women show similar survival rates after breast cancer

verfasst von: Yin Pan, Ze-Zhou Song

Erschienen in: Journal of Cancer Research and Clinical Oncology | Ausgabe 8/2017

Einloggen, um Zugang zu erhalten

Excerpt

To the editors: With great interests, we read the article by Prof. Bender et al. (2017), which concluded that there was no significant difference in prognosis between male and female breast cancer cases. …

Bender PMF, Oliveira LL, Costa CR et al (2017) Men and women show similar survival rates after breast cancer. J Cancer Res Clin Oncol 143:563–571CrossRefPubMed

Foerster R, Foerster F, Wulff V et al (2011) Matched-pair analysis of patients with female and male breast cancer: a comparative analysis. BMC Cancer 11:335–348CrossRefPubMedPubMedCentral

Gnerlich J, Deshpande A, Jeffe DB et al (2011) Poorer survival outcomes for male breast cancer compared with female breast cancer may be attributable to in-stage migration. Ann Surg Oncol 18:1837–1844CrossRefPubMed

Yu XF, Yang HJ, Yu Y et al (2015) A prognostic analysis of male breast cancer (MBC) compared with post-menopausal female breast cancer (FBC). PLoS ONE 10:e0136670CrossRefPubMedPubMedCentral

Titel: Commentary on: Men and women show similar survival rates after breast cancer
verfasst von: Yin Pan
Ze-Zhou Song
Publikationsdatum: 08.06.2017
Verlag: Springer Berlin Heidelberg
Erschienen in: Journal of Cancer Research and Clinical Oncology / Ausgabe 8/2017
Print ISSN: 0171-5216
Elektronische ISSN: 1432-1335
DOI: https://doi.org/10.1007/s00432-017-2443-1

Neu im Fachgebiet Onkologie

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Commentary on: Men and women show similar survival rates after breast cancer

Excerpt

Neu im Fachgebiet Onkologie

Prostatakarzinom: EU initiiert neues Screeningkonzept

Blasenkarzinom – Biomarker statt Zytologie?

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Adjuvante Brustkrebstherapie: Doppelt hält besser

Update Onkologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2017

Cancer patients’ preferences for therapy decisions can be grouped into categories and separated by demographic factors

Efficacy and safety of percutaneous ultrasound guided radiofrequency ablation for treating cervical metastatic lymph nodes from papillary thyroid carcinoma

Solute carrier organic anion transporter family member 4A1 (SLCO4A1) as a prognosis marker of colorectal cancer

Doublecortin and CaM kinase-like-1 expression in pathological stage I non-small cell lung cancer

Clinical pharmacology and clinical trials of ribonucleotide reductase inhibitors: is it a viable cancer therapy?

Impact of age on efficacy and toxicity of nilotinib in patients with chronic myeloid leukemia in chronic phase: ENEST1st subanalysis

Neu im Fachgebiet Onkologie

Prostatakarzinom: EU initiiert neues Screeningkonzept

Blasenkarzinom – Biomarker statt Zytologie?

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Adjuvante Brustkrebstherapie: Doppelt hält besser

Update Onkologie